Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition

por Xue, Tong-Chun, Ge, Ning-Ling, Zhang, Lan, Cui, Jie-Feng, Chen, Rong-Xin, You, Yang, Ye, Sheng-Long, Ren, Zheng-Gang
Publicado 2014

Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis

por Xue, Tong-Chun, Zhang, Lan, Xie, Xiao-Yin, Ge, Ning-Ling, Li, Li-Xin, Zhang, Bo-Heng, Ye, Sheng-Long, Ren, Zheng-Gang
Publicado 2014

Hepatitis B surface antigen predicts recurrence after radiofrequency ablation in patients with low hepatitis B virus loads

por Zhang, Lan, Xie, Xiao-Ying, Chen, Yi, Ge, Ning-Ling, Chen, Rong-Xin, Gan, Yu-Hong, Zhang, Bo-Heng, Wang, Yan-Hong, Ren, Zheng-Gang
Publicado 2017

A new prediction model for prognosis of patients with intermediate-stage HCC after conventional transarterial chemoembolization: an internally validated study

por Chen, Rong-Xin, Gan, Yu-Hong, Ge, Ning-Ling, Chen, Yi, Ma, Min, Zhang, Bo-Heng, Wang, Yan-Hong, Ye, Sheng-Long, Luo, Jian-Feng, Ren, Zheng-Gang
Publicado 2019

Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis

por Huang, Cheng, Zhu, Xiao-Dong, Shen, Ying-Hao, Wu, Dong, Ji, Yuan, Ge, Ning-Ling, Chen, Ling-Li, Tan, Chang-Jun, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan
Publicado 2021

Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An An...

por Li, Jing-huan, Yin, Xin, Fan, Wen-shuai, Zhang, Lan, Chen, Rong-xin, Chen, Yi, Li, Li-xin, Ge, Ning-ling, Gan, Yu-hong, Wang, Yan-hong, Ren, Zheng-gang
Publicado 2021

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

por Zhu, Xiao-Dong, Huang, Cheng, Shen, Ying-Hao, Xu, Bin, Ge, Ning-Ling, Ji, Yuan, Qu, Xu-Dong, Chen, Lingli, Chen, Yi, Li, Mei-Ling, Zhu, Jin-Jin, Tang, Zhao-You, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan
Publicado 2022

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 stu...

por Shi, Guo-Ming, Huang, Xiao-Yong, Wu, Dong, Sun, Hui-Chuan, Liang, Fei, Ji, Yuan, Chen, Yi, Yang, Guo-Huan, Lu, Jia-Cheng, Meng, Xian-Long, Wang, Xin-Ying, Sun, Lei, Ge, Ning-Ling, Huang, Xiao-Wu, Qiu, Shuang-Jian, Yang, Xin-Rong, Gao, Qiang, He, Yi-Feng, Xu, Yang, Sun, Jian, Ren, Zheng-Gang, Fan, Jia, Zhou, Jian
Publicado 2023

Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study

por Huang, Cheng, Zhu, Xiao-Dong, Shen, Ying-Hao, Xu, Bin, Wu, Dong, Ji, Yuan, Chen, Ling-Li, Song, Tian-Qiang, Zhang, Wei, Zeng, Zhi-Ming, Huang, Hua-Sheng, Wang, Kui, Huang, Lan-Qing, Chen, Yong-Jun, Yang, Yu-Chen, Zhou, Le-Du, Long, Guo, Zhao, Hai-Tao, Wang, Yun-Chao, Ge, Ning-Ling, Chen, Yi, Tan, Chang-Jun, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan
Publicado 2023